GlobalData on MSN14d
EC approves GSK’s Menveo vaccine presentation for IMDThe European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
Zacks.com on MSN14d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine MenveoGSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...
In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...
European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback